This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia, L. S.
Right arrow Articles by Garcia, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, L. S.
Right arrow Articles by Garcia, J. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2006, p. 4587-4588, Vol. 44, No. 12
0095-1137/06/$08.00+0     doi:10.1128/JCM.01458-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Detection of Giardia lamblia Antigens in Human Fecal Specimens by a Solid-Phase Qualitative Immunochromatographic Assay{triangledown}

Lynne S. Garcia1* and John Paul Garcia2

LSG & Associates, Santa Monica, California 90402,1 VA Greater Los Angeles Healthcare System, Los Angeles, California 900732

Received 14 July 2006/ Returned for modification 17 August 2006/ Accepted 9 October 2006


arrow
ABSTRACT
 
The SIMPLE-READ Giardia rapid assay (Medical Chemical Corporation) is a solid-phase qualitative immunochromatographic assay that detects Giardia lamblia in aqueous extracts of human fecal specimens. Testing 106 Giardia-positive and 104 Giardia-negative stool specimens yielded a sensitivity of 97.2% and a specificity of 100% for the SIMPLE-READ Giardia rapid assay.


arrow
TEXT
 
Revised ordering options related to diagnostic parasitology testing include ova and parasite (O&P) examinations, the newer fecal immunoassays, and special stains for the coccidia and microsporidia. Laboratories are incorporating these procedures into their test menus, and each of the three test options has very specific benefits in terms of clinically relevant testing. While the use of routine diagnostic methods such as fecal concentration, permanent stained smears, and modified acid-fast staining may be insufficient to demonstrate the presence of intestinal parasites, antigen detection assays for Cryptosporidium spp. and Giardia lamblia have proven to be very useful (1-9, 12-15).

As acute infections with G. lamblia resolve, the number of organisms shed in the stool varies dramatically and the number of cysts passed by patients, including those who may be compromised, varies from day to day and week to week, particularly if they do not have diarrhea (10).

The nonenzymatic rapid immunoassay for Giardia antigens (SIMPLE-READ Giardia rapid assay; Medical Chemical Corp.) was performed in approximately 10 min on formalin-fixed (5 or 10% formalin or sodium acetate-acetic acid-formalin) stool specimens. Sample treatment buffer (4 to 6 drops) was added to a tube, followed by 1 drop of the uncentrifuged stool specimen. After the sample was mixed, it was immediately poured into the membrane flow test device. Using specific antibodies, Giardia antigens are isolated and immobilized on the substrate. Since the specimens were submitted in fixative, no mixing of the fecal sample was required prior to sampling; fluid above the stool was used, since the antigen was in solution. The assay results were read visually after 10 min. Positive results were seen as pink lines (regardless of intensity) on the membrane in the results window. A control was included in the device and visually appeared as a strong pink line.

In this study, the cartridge was tested against unconcentrated known positive and negative 10% formalin- or sodium acetate-acetic acid-formalin-preserved fecal specimens. The known positive and negative results were based on the reference methods, which were the O&P examination (concentration and permanent stained smear), the Meridian Bioscience, Inc., Giardia/Cryptosporidium Merifluor FA reagent, and the Medical-Chemical Corp. Para-Tect Giardia/Cryptosporidium FA reagent. For discrepant results obtained using the cartridge, if the specimen was positive by any two reference methods, the specimen was considered a true positive. Three specimens that tested negative using the cartridge were confirmed as true positives with very low parasite numbers by both of the more sensitive FA reference methods. Four specimens determined to be positive using the cartridge were originally considered negative based on the O&P examination; however, when retested, the four specimens were confirmed as true positives using the two FA reference methods.

Of the 210 specimens examined, 106 were positive for Giardia based on the results of the reference methods. Different parasites (10 protozoa, including trophozoites, cysts, and oocysts; seven helminths, including eggs and larvae; and four specimens containing human cells [polymorphonuclear leukocytes and macrophages]) were included in the negative specimens (n = 104). Both positive and negative specimens were tested by the two sites, 158 at LSG & Associates and 52 at the VA Greater Los Angeles facility. The known positive and negative specimens were randomly assigned to the two testing sites. All specimens were patient specimens, not seeded specimens, and some contained multiple organisms. Specific organisms included Blastocystis hominis (n = 16), Cryptosporidium spp. (n = 34), Cyclospora cayetanensis (n = 1), Chilomastix mesnili (n = 1), Dientamoeba fragilis (n = 6), Endolimax nana (n = 23), Entamoeba coli (n = 12), Entamoeba hartmanni (n = 1), Entamoeba histolytica/Entamoeba dispar (n = 7), Iodamoeba bütschlii (n = 3), Ascaris lumbricoides (n = 7), Diphyllobothrium latum (n = 1), Enterobius vermicularis (n = 5), Hymenolepis nana (n = 8), Strongyloides stercoralis (n = 4), Taenia spp. (n = 3), and Trichuris trichiura (n = 3). Although the results of the reference methods were known, the specimens were coded and tested blind when the SIMPLE-READ cartridge was used.

After resolution, the total number of positive specimens was 106, the sensitivity was 97.2%, the specificity was 100%, the positive predictive value (predictive value of a positive test result) was 100%, and the negative predictive value (predictive value of a negative test result) was 97.2% (Table 1). False-negative G. lamblia results were obtained from three specimens with low parasite numbers (one or two cysts/well using immunofluorescence). No cross-reactions were seen with other parasites.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Comparison of results with the reference methods and the SIMPLE-READ cartridgea

In patients with giardiasis, the use of routine diagnostic methods such as concentration and permanent stain may be insufficient to demonstrate the presence of these organisms (5, 15). Although the fecal immunoassays are more sensitive than the routine O&P method, false-negative results may still occur with very light infections. It has been recommended that a second specimen be tested if the first fecal immunoassay for suspected giardiasis is negative (11).

Although the reagent costs may be more than those for the routine O&P methods, the labor costs will be considerably less when using the rapid cartridge format. When comparing diagnostic test costs, it is important to consider all aspects of testing including, but not limited to, reagents, labor, repeat tests, quality control, reagent storage, number of tests requested, staff expertise in microscopy, and training requirements.

The ability to detect Giardia antigens in formalin-fixed or unfixed fecal specimens with a 10-min nonenzymatic immunoassay provides the user with another useful diagnostic kit, the SIMPLE-READ Giardia rapid assay (Medical Chemical Corp.), which can also be used at the point of service like other rapid immunoassays currently available. The rapid immunoassays do not take the place of routine O&P examinations, but they are more sensitive and clinically relevant when trying to diagnose specific infections such as giardiasis (5).


arrow
ACKNOWLEDGMENTS
 
We thank Medical Chemical Corporation for providing the SIMPLE-READ diagnostic kits and the confirmative diagnostic kits.

We thank Medical Chemical Corporation for financial support.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: LSG & Associates, 512 12th St., Santa Monica, CA 90402-2908. Phone: (310) 393-5059. Fax: (310) 899-9722. E-mail: Lynnegarcia2{at}earthlink.net. Back

{triangledown} Published ahead of print on 25 October 2006. Back


arrow
REFERENCES
 
    1
  1. Aldeen, W. E., K. Carroll, A. Robison, M. Morrison, and D. Hale. 1998. Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of Giardia lamblia in fecal specimens. J. Clin. Microbiol. 36:1338-1340.[Abstract/Free Full Text]
    2. 2
  2. Boone, J. H., T. D. Wilkins, T. E. Nash, J. E. Brandon, E. A. Macias, R. C. Jerris, and D. M. Lyerly. 1999. TechLab and Alexon Giardia enzyme-linked immunosorbent assay kits detect cyst wall protein 1. J. Clin. Microbiol. 37:611-614.[Abstract/Free Full Text]
    3. 3
  3. Chan, R., J. Chen, M. K. York, N. Setijono, R. L. Kaplan, F. Graham, and H. B. Tanowitz. 2000. Evaluation of a combination rapid immunoassay for detection of Giardia and Cryptosporidium antigens. J. Clin. Microbiol. 38:393-394.[Abstract/Free Full Text]
    4. 4
  4. Garcia, L. S. 2007. Diagnostic medical parasitology, 5th ed. ASM Press, Washington, D.C.
    5. 5
  5. Garcia, L. S., and R. Y. Shimizu. 1997. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for the detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J. Clin. Microbiol. 35:1526-1529.[Abstract]
    6. 6
  6. Garcia, L. S., and R. Y. Shimizu. 2000. Detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens using the ColorPAC combination rapid solid-phase qualitative immunochromatographic assay. J. Clin. Microbiol. 38:1267-1268.[Abstract/Free Full Text]
    7. 7
  7. Garcia, L. S., R. Y. Shimizu, and C. N. Bernard. 2000. Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the Triage Parasite Panel enzyme immunoassay. J. Clin. Microbiol. 38:3337-3340.[Abstract/Free Full Text]
    8. 8
  8. Garcia, L. S., R. Y. Shimizu, S. Novak, M. Carroll, and F. Chan. 2003. Commercial assay for detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens by rapid solid-phase qualitative immunochromatography. J. Clin. Microbiol. 41:209-212.[Abstract/Free Full Text]
    9. 9
  9. Garcia, L. S., A. C. Shum, and D. A. Bruckner. 1992. Evaluation of a new monoclonal antibody combination reagent for direct fluorescent detection of Giardia cysts and Cryptosporidium oocysts in human fecal specimens. J. Clin. Microbiol. 30:3255-3257.[Abstract/Free Full Text]
    10. 10
  10. Handoussa, A. E., M. M. Helmy, E. M. Hussein, and H. I. El-Nimr. 2005. Degree of symptoms versus copro-antigen levels in Giardia lamblia infection. J. Egypt. Soc. Parasitol. 35:69-81.[Medline]
    11. 11
  11. Hanson, K. L., and C. P. Cartwright. 2001. Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia. J. Clin. Microbiol. 39:474-477.[Abstract/Free Full Text]
    12. 12
  12. Katanik, M. T., S. K. Schneider, J. E. Rosenblatt, G. S. Hall, and G. W. Procop. 2001. Evaluation of ColorPAC Giardia/Cryptosporidium rapid assay and ProSpecT Giardia/Cryptosporidium microplate assay for detection of Giardia and Cryptosporidium in fecal specimens. J. Clin. Microbiol. 39:4523-4525.[Abstract/Free Full Text]
    13. 13
  13. Rosenblatt, J. E., L. M. Sloan, and S. K. Schneider. 1993. Evaluation of an enzyme-linked immunosorbent assay for the detection of Giardia lamblia in stool specimens. Diagn. Microbiol. Infect. Dis. 16:337-341.[CrossRef][Medline]
    14. 14
  14. Rosoff, J. D., C. A. Sanders, S. S. Sonnad, P. R. De Lay, W. K. Hadley, F. F. Vincenzi, D. M. Yajko, and P. D. O'Hanley. 1989. Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65). J. Clin. Microbiol. 27:1997-2002.[Abstract/Free Full Text]
    15. 15
  15. Zimmerman, S. K., and C. A. Needham. 1995. Comparison of conventional stool concentration and preserved-smear methods with Merifluor Cryptosporidium/Giardia direct immunofluorescence assay and ProSpecT Giardia EZ microplate assay for detection of Giardia lamblia. J. Clin. Microbiol. 33:1942-1943.[Abstract]

Journal of Clinical Microbiology, December 2006, p. 4587-4588, Vol. 44, No. 12
0095-1137/06/$08.00+0     doi:10.1128/JCM.01458-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia, L. S.
Right arrow Articles by Garcia, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, L. S.
Right arrow Articles by Garcia, J. P.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»